news

IQVIA's Q2 Blowout Raises Concerns About Clinical Trial Outsourci

The Hidden Costs of Clinical Trial Outsourcing IQVIA Holdings Inc.

's recent financial results sent shockwaves through the healthcare industry, sparking concerns about the true cost of outsourcing clinical trials to large scale operators.

On the surface, the numbers look impressive: record bookings, increased revenue, and a solid earnings beat for Q2 2026. However, upon closer inspection, a more nuanced picture emerges. The $3.

Read the full story

Read on Topicd →